A carregar...
Alternative Facts and the ICER Proposed Policy on Access to Imaginary Pharmacoeconomic Worlds
The Institute for Clinical and Economic Review (ICER) announced at the end of March 2018 that it proposed to share executable draft economic models with relevant drug manufacturers during ICER evidence reviews. Taken at face value, ICER is offering manufacturers and other interested parties the poss...
Na minha lista:
| Publicado no: | Innov Pharm |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
University of Minnesota Libraries Publishing
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6438559/ https://ncbi.nlm.nih.gov/pubmed/34007702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.24926/iip.v9i2.1300 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|